STOCK TITAN

ZimVie Announces Upcoming Changes to Company's Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

ZimVie (Nasdaq: ZIMV), a global dental implant market leader, announced key changes to its Board of Directors. David King, Non-Executive Chair, will not seek reelection when his term expires at the May 7, 2025 shareholders meeting.

Current President and CEO Vafa Jamali will assume the role of Chairman of the Board, while Director Vinit Asar will become Lead Independent Director. Asar, a board member since 2022, currently chairs the Quality, Regulatory, and Technology Committee and serves on the Audit, Corporate Governance, and Compensation Committees.

Under Jamali's leadership since the company's spinoff, ZimVie has transformed into a focused dental company, reduced debt to enhance financial flexibility, and streamlined operations. Asar also serves as Executive Chairman of Hanger, Inc.

ZimVie (Nasdaq: ZIMV), leader globale nel mercato degli impianti dentali, ha annunciato importanti cambiamenti nel suo Consiglio di Amministrazione. David King, Presidente Non Esecutivo, non si ricandiderà quando il suo mandato scadrà nell'assemblea degli azionisti del 7 maggio 2025.

L'attuale Presidente e CEO Vafa Jamali assumerà il ruolo di Presidente del Consiglio, mentre il Direttore Vinit Asar diventerà Direttore Indipendente Principale. Asar, membro del consiglio dal 2022, attualmente presiede il Comitato per la Qualità, la Regolamentazione e la Tecnologia e fa parte dei Comitati di Revisione, Governance Aziendale e Compensazione.

Sotto la guida di Jamali dalla scissione dell'azienda, ZimVie si è trasformata in un'azienda dentale focalizzata, ha ridotto il debito per migliorare la flessibilità finanziaria e ha semplificato le operazioni. Asar funge anche da Presidente Esecutivo di Hanger, Inc.

ZimVie (Nasdaq: ZIMV), líder global en el mercado de implantes dentales, anunció cambios clave en su Junta Directiva. David King, Presidente No Ejecutivo, no buscará la reelección cuando su mandato expire en la reunión de accionistas del 7 de mayo de 2025.

El actual Presidente y CEO Vafa Jamali asumirá el cargo de Presidente de la Junta, mientras que el Director Vinit Asar se convertirá en Director Independiente Principal. Asar, miembro de la junta desde 2022, actualmente preside el Comité de Calidad, Regulación y Tecnología y forma parte de los Comités de Auditoría, Gobernanza Corporativa y Compensación.

Bajo el liderazgo de Jamali desde la escisión de la empresa, ZimVie se ha transformado en una empresa dental enfocada, ha reducido la deuda para mejorar la flexibilidad financiera y ha optimizado las operaciones. Asar también es Presidente Ejecutivo de Hanger, Inc.

ZimVie (Nasdaq: ZIMV), 글로벌 치과 임플란트 시장의 선두주자, 이사회에 대한 주요 변경 사항을 발표했습니다. David King, 비상임 의장은 2025년 5월 7일 주주총회에서 임기가 만료될 때 재선에 나서지 않을 것입니다.

현재 사장 겸 CEO인 Vafa Jamali는 이사회 의장직을 맡게 되며, 이사 Vinit Asar는 수석 독립 이사가 됩니다. Asar는 2022년부터 이사로 재직 중이며, 현재 품질, 규제 및 기술 위원회를 주재하고 감사, 기업 거버넌스 및 보상 위원회에도 참여하고 있습니다.

Jamali의 지도 아래 ZimVie는 회사 분사 이후 집중된 치과 회사로 탈바꿈했으며, 재정 유연성을 높이기 위해 부채를 줄이고 운영을 간소화했습니다. Asar는 또한 Hanger, Inc.의 집행 의장으로 활동하고 있습니다.

ZimVie (Nasdaq: ZIMV), leader mondial sur le marché des implants dentaires, a annoncé des changements clés au sein de son Conseil d'Administration. David King, Président Non Exécutif, ne se représentera pas lorsque son mandat expirera lors de l'assemblée des actionnaires du 7 mai 2025.

L'actuel Président et CEO Vafa Jamali assumera le rôle de Président du Conseil, tandis que le Directeur Vinit Asar deviendra Directeur Indépendant Principal. Asar, membre du conseil depuis 2022, préside actuellement le Comité de Qualité, de Réglementation et de Technologie et siège également aux Comités d'Audit, de Gouvernance d'Entreprise et de Rémunération.

Sous la direction de Jamali depuis la scission de l'entreprise, ZimVie s'est transformée en une entreprise dentaire ciblée, a réduit sa dette pour améliorer sa flexibilité financière et a rationalisé ses opérations. Asar est également Président Exécutif de Hanger, Inc.

ZimVie (Nasdaq: ZIMV), ein globaler Marktführer im Bereich Zahnimplantate, gab wichtige Änderungen im Vorstand bekannt. David King, nicht geschäftsführender Vorsitzender, wird sich bei der Hauptversammlung der Aktionäre am 7. Mai 2025 nicht zur Wiederwahl stellen.

Der derzeitige Präsident und CEO Vafa Jamali wird den Vorsitz des Vorstands übernehmen, während der Direktor Vinit Asar zum leitenden unabhängigen Direktor ernannt wird. Asar, der seit 2022 im Vorstand ist, leitet derzeit den Ausschuss für Qualität, Regulierung und Technologie und ist Mitglied des Ausschusses für Prüfung, Unternehmensführung und Vergütung.

Unter Jamalis Führung hat sich ZimVie seit der Abspaltung des Unternehmens zu einem fokussierten Dentalunternehmen entwickelt, die Schulden reduziert, um die finanzielle Flexibilität zu erhöhen, und die Abläufe optimiert. Asar ist auch geschäftsführender Vorsitzender von Hanger, Inc.

Positive
  • Consolidation of leadership under CEO who has proven track record of creating shareholder value
  • Successful debt reduction improving financial flexibility
  • Strategic transformation into focused dental company completed
  • Appointment of experienced Lead Independent Director maintaining governance balance
Negative
  • Loss of experienced Non-Executive Chair could impact board oversight
  • Concentration of power with CEO assuming Chairman role

PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including: 

  • Non-Executive Chair David King will not stand for reelection as a director upon the expiration of his current term at the Company's annual meeting of shareholders on May 7, 2025.
  • President and CEO Vafa Jamali will be appointed Chairman of the Board effective as of May 7, 2025.
  • Director Vinit Asar will be appointed Lead Independent Director effective upon the commencement of Mr. Jamali’s service as Chairman.

Retirement of Mr. King

“On behalf of ZimVie and our Board of Directors, I want to extend our deepest gratitude to David for his leadership and service as Chair during a pivotal time for the Company,” said Mr. Jamali. “His experience in the healthcare and life science sectors has been instrumental in shaping ZimVie’s strategic direction and positioning our Company for success.”

Appointment of Mr. Jamali as Chairman of the Board 

“Through his leadership as President and CEO since the spinoff three years ago, Vafa has created significant shareholder value while transforming ZimVie into a pure play dental company, substantially reduced debt to improve the company’s financial health and flexibility, and streamlined its operations,” said Mr. King. “The Board of Directors is confident Vafa will drive even stronger value for ZimVie’s stakeholders in his expanded role as Chairman.”

Appointment of Mr. Asar as Lead Independent Director

Mr. Asar has been a member of ZimVie’s Board of Directors since 2022. He currently serves as Chair of the Quality, Regulatory, and Technology Committee and as a member of each of the Audit, Corporate Governance, and Compensation Committees. Mr. Asar currently serves as the Executive Chairman of the Board of Hanger, Inc. Mr. Jamali stated, "We are honored to have Vinit serve as our Lead Independent Director. He provides valuable strategic perspective as a Board member, and I look forward to working with him in his new role.”

About ZimVie
ZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at www.ZimVie.com. Follow @ZimVie on TwitterFacebookLinkedIn, or Instagram.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, stakeholder value, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.

Media Contact Information:

ZimVie
Grace Flowers • Grace.Flowers@ZimVie.com
(561) 319-6130

Investor Contact Information:

Gilmartin Group LLC
Webb Campbell • Webb@gilmartinir.com


FAQ

When will ZimVie (ZIMV) implement its Board of Directors changes?

The changes will take effect on May 7, 2025, during ZimVie's annual meeting of shareholders.

Who will replace David King as Chairman of ZimVie (ZIMV)?

Current President and CEO Vafa Jamali will assume the role of Chairman of the Board.

What major achievements has Vafa Jamali accomplished at ZimVie (ZIMV)?

Jamali has transformed ZimVie into a pure play dental company, reduced debt, improved financial health, and streamlined operations.

What role will Vinit Asar take on at ZimVie (ZIMV)?

Vinit Asar will become Lead Independent Director and continue serving on multiple board committees.
ZIMVIE INC

NASDAQ:ZIMV

ZIMV Rankings

ZIMV Latest News

ZIMV Stock Data

324.38M
26.93M
1.93%
92.19%
1.32%
Medical Devices
Dental Equipment & Supplies
Link
United States
PALM BEACH GARDEN